| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
131,512 |
119,531 |
$16.89M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
111,474 |
92,882 |
$16.21M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
71,660 |
58,113 |
$11.72M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
101,531 |
87,069 |
$9.27M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
16,473 |
9,499 |
$5.90M |
| J9271 |
Injection, pembrolizumab, 1 mg |
797 |
454 |
$5.42M |
| 70450 |
Computed tomography, head or brain; without contrast material |
15,467 |
12,335 |
$4.49M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
55,820 |
15,068 |
$4.12M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
29,981 |
27,617 |
$3.43M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
11,721 |
8,812 |
$3.26M |
| G0378 |
Hospital observation service, per hour |
34,276 |
14,178 |
$2.47M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
13,880 |
8,751 |
$2.14M |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
7,681 |
3,984 |
$2.03M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
3,701 |
2,884 |
$1.67M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
5,075 |
3,836 |
$1.48M |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
10,613 |
6,344 |
$1.46M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
10,698 |
5,224 |
$1.42M |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
6,174 |
4,683 |
$1.02M |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
2,005 |
1,623 |
$843K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
8,182 |
5,822 |
$812K |
| 76820 |
|
7,865 |
4,579 |
$793K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
8,546 |
6,908 |
$764K |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
2,456 |
424 |
$758K |
| 80053 |
Comprehensive metabolic panel |
90,030 |
67,885 |
$694K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
4,538 |
4,342 |
$667K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,236 |
926 |
$662K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,877 |
2,496 |
$661K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
878 |
791 |
$648K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
9,812 |
4,419 |
$620K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
83,636 |
63,349 |
$583K |
| 70496 |
|
2,165 |
1,560 |
$548K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
4,482 |
4,439 |
$541K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,700 |
4,545 |
$540K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
3,407 |
3,244 |
$519K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,056 |
2,954 |
$514K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,645 |
4,403 |
$489K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
4,686 |
4,171 |
$474K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
945 |
724 |
$473K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
3,504 |
2,441 |
$385K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,476 |
1,218 |
$385K |
| 95811 |
|
569 |
527 |
$383K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
5,002 |
1,861 |
$356K |
| 93325 |
|
2,144 |
1,987 |
$355K |
| 64493 |
|
529 |
353 |
$352K |
| 93458 |
|
313 |
230 |
$349K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
731 |
608 |
$346K |
| A0431 |
Ambulance service, conventional air services, transport, one way (rotary wing) |
224 |
216 |
$339K |
| 84443 |
Thyroid stimulating hormone (TSH) |
19,452 |
16,292 |
$336K |
| 70491 |
|
1,075 |
789 |
$326K |
| J0897 |
Injection, denosumab, 1 mg |
372 |
272 |
$326K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
267 |
156 |
$324K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
2,937 |
1,518 |
$323K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
160,936 |
121,580 |
$323K |
| 71046 |
Radiologic examination, chest; 2 views |
29,418 |
25,586 |
$321K |
| 76821 |
|
3,649 |
2,036 |
$314K |
| 76770 |
|
1,775 |
1,582 |
$314K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,042 |
2,785 |
$308K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
10,687 |
3,760 |
$297K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
3,175 |
2,660 |
$296K |
| 76801 |
|
2,450 |
2,175 |
$296K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
2,403 |
1,739 |
$294K |
| 80061 |
Lipid panel |
12,398 |
11,140 |
$287K |
| 84484 |
|
69,394 |
36,662 |
$280K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,311 |
2,268 |
$279K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,449 |
1,202 |
$274K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,749 |
1,417 |
$273K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,286 |
2,229 |
$252K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
78,005 |
58,917 |
$247K |
| 49083 |
|
632 |
261 |
$246K |
| 36415 |
Collection of venous blood by venipuncture |
122,918 |
91,641 |
$240K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
427 |
295 |
$239K |
| 64635 |
|
418 |
268 |
$235K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,466 |
2,236 |
$231K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
8,330 |
7,378 |
$227K |
| 97161 |
|
4,708 |
4,030 |
$215K |
| 95816 |
|
1,262 |
1,201 |
$210K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
1,373 |
1,176 |
$207K |
| 93017 |
|
2,216 |
1,801 |
$204K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
18,356 |
16,715 |
$201K |
| 12001 |
|
1,132 |
995 |
$200K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
871 |
777 |
$190K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
3,843 |
3,507 |
$187K |
| 97113 |
|
2,556 |
708 |
$185K |
| 93976 |
|
1,203 |
925 |
$181K |
| 76813 |
|
1,825 |
1,700 |
$174K |
| 77386 |
|
406 |
37 |
$171K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
7,881 |
6,719 |
$167K |
| 10060 |
|
922 |
763 |
$166K |
| 76825 |
|
1,798 |
1,645 |
$164K |
| 97016 |
|
5,402 |
1,538 |
$164K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
69,791 |
54,002 |
$163K |
| 96416 |
|
533 |
202 |
$158K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
18,808 |
15,684 |
$155K |
| 74174 |
|
670 |
516 |
$152K |
| 96415 |
|
1,039 |
531 |
$151K |
| 76827 |
|
1,894 |
1,745 |
$150K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,019 |
804 |
$149K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
3,633 |
1,159 |
$147K |
| 93970 |
|
957 |
810 |
$147K |
| 71045 |
Radiologic examination, chest; single view |
36,487 |
30,156 |
$143K |
| 90870 |
|
428 |
165 |
$142K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
8,238 |
6,340 |
$135K |
| 76642 |
|
1,237 |
1,033 |
$133K |
| 76818 |
|
1,869 |
1,031 |
$130K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
487 |
308 |
$129K |
| 74018 |
|
2,857 |
2,347 |
$124K |
| 12011 |
|
737 |
628 |
$123K |
| 71250 |
|
1,436 |
1,210 |
$119K |
| 71271 |
|
1,041 |
944 |
$116K |
| 72141 |
|
785 |
665 |
$116K |
| 85027 |
|
23,607 |
17,080 |
$114K |
| 97162 |
|
3,144 |
2,618 |
$113K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
906 |
882 |
$110K |
| 74183 |
|
472 |
385 |
$109K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
5,686 |
4,493 |
$108K |
| 94060 |
|
899 |
805 |
$108K |
| 72131 |
|
1,694 |
1,301 |
$107K |
| 86900 |
|
4,988 |
3,720 |
$107K |
| 12002 |
|
613 |
539 |
$106K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
11,816 |
11,140 |
$100K |
| 76536 |
|
890 |
807 |
$100K |
| 52356 |
|
50 |
31 |
$97K |
| 93975 |
|
652 |
486 |
$97K |
| 93971 |
|
1,196 |
1,011 |
$95K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
688 |
546 |
$91K |
| 96367 |
|
2,310 |
1,389 |
$87K |
| 80320 |
|
7,726 |
5,944 |
$86K |
| 84439 |
|
6,834 |
5,849 |
$86K |
| 82607 |
|
5,107 |
4,504 |
$86K |
| 87510 |
|
12,755 |
10,300 |
$84K |
| 72100 |
|
2,961 |
2,462 |
$83K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
116 |
50 |
$81K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
678 |
515 |
$81K |
| 47562 |
|
23 |
14 |
$79K |
| 97535 |
Self-care/home management training, each 15 minutes |
2,550 |
1,480 |
$78K |
| 84702 |
|
5,151 |
3,615 |
$77K |
| G0008 |
Administration of influenza virus vaccine |
7,293 |
7,006 |
$75K |
| 73700 |
|
642 |
492 |
$74K |
| 77336 |
|
782 |
342 |
$73K |
| 70498 |
|
2,307 |
1,673 |
$72K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
24,527 |
20,374 |
$71K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
4,124 |
3,595 |
$71K |
| 82805 |
|
1,991 |
1,387 |
$70K |
| 73562 |
|
4,510 |
3,667 |
$67K |
| 97116 |
|
3,188 |
1,433 |
$65K |
| 11045 |
|
221 |
134 |
$65K |
| 86780 |
|
2,737 |
2,297 |
$65K |
| 76830 |
Ultrasound, transvaginal |
1,824 |
1,412 |
$65K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
57,362 |
42,709 |
$65K |
| 90686 |
|
5,552 |
5,311 |
$64K |
| 83655 |
|
1,822 |
1,735 |
$63K |
| 77334 |
|
135 |
92 |
$63K |
| 77300 |
|
132 |
102 |
$62K |
| A9609 |
Fludeoxyglucose f18 up to 15 millicuries |
246 |
227 |
$61K |
| 83550 |
|
4,305 |
3,701 |
$61K |
| 82728 |
|
4,515 |
3,895 |
$59K |
| 83735 |
|
24,115 |
17,375 |
$59K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
51,820 |
34,731 |
$59K |
| 82746 |
|
4,116 |
3,622 |
$59K |
| 96161 |
|
228 |
211 |
$58K |
| 73630 |
|
5,119 |
4,236 |
$58K |
| 70486 |
|
1,407 |
1,087 |
$58K |
| 97166 |
|
1,505 |
1,176 |
$57K |
| 82947 |
|
29,947 |
13,971 |
$56K |
| 36430 |
|
563 |
356 |
$56K |
| 73221 |
|
270 |
233 |
$55K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
18,179 |
15,175 |
$55K |
| 97165 |
|
772 |
636 |
$55K |
| 86140 |
|
5,706 |
4,182 |
$55K |
| 86850 |
|
4,517 |
3,428 |
$54K |
| 87660 |
|
12,921 |
10,461 |
$53K |
| 58558 |
|
36 |
31 |
$53K |
| 94726 |
|
803 |
717 |
$52K |
| 86803 |
|
2,101 |
1,855 |
$52K |
| 72040 |
|
1,416 |
1,207 |
$51K |
| 73030 |
|
3,621 |
2,860 |
$51K |
| A0425 |
Ground mileage, per statute mile |
994 |
939 |
$51K |
| 72197 |
|
212 |
173 |
$50K |
| 94729 |
|
825 |
734 |
$50K |
| 80076 |
|
10,157 |
7,827 |
$50K |
| 83970 |
|
1,519 |
1,295 |
$48K |
| 81001 |
|
60,127 |
50,408 |
$48K |
| 88307 |
|
544 |
321 |
$47K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
3,743 |
3,421 |
$46K |
| 83516 |
|
2,018 |
1,055 |
$46K |
| 94664 |
|
2,228 |
1,820 |
$45K |
| 95951 |
|
103 |
37 |
$45K |
| 85055 |
|
4,211 |
2,968 |
$44K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
18,813 |
15,692 |
$44K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
212 |
120 |
$43K |
| 87506 |
|
375 |
296 |
$41K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
1,205 |
868 |
$41K |
| 83540 |
|
4,723 |
4,050 |
$41K |
| 73610 |
|
3,867 |
3,159 |
$40K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
260 |
249 |
$40K |
| 93798 |
|
905 |
145 |
$40K |
| J3490 |
Unclassified drugs |
749 |
335 |
$40K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
480 |
339 |
$39K |
| 36591 |
|
11,245 |
5,660 |
$38K |
| J1756 |
Injection, iron sucrose, 1 mg |
1,785 |
674 |
$38K |
| 90670 |
|
3,889 |
3,829 |
$37K |
| 90651 |
|
747 |
691 |
$37K |
| 73130 |
|
4,403 |
3,644 |
$36K |
| 90715 |
|
2,252 |
1,848 |
$35K |
| 83880 |
|
9,825 |
7,586 |
$35K |
| 73502 |
|
2,190 |
1,773 |
$34K |
| 72128 |
|
901 |
680 |
$34K |
| 88341 |
|
604 |
321 |
$34K |
| 95800 |
|
124 |
113 |
$33K |
| 85610 |
|
17,286 |
11,732 |
$32K |
| 96523 |
|
538 |
243 |
$32K |
| 83525 |
|
1,045 |
932 |
$31K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
219 |
77 |
$30K |
| 36561 |
|
35 |
27 |
$30K |
| 74230 |
|
235 |
202 |
$30K |
| J0588 |
Injection, incobotulinumtoxin a, 1 unit |
33 |
25 |
$30K |
| 82570 |
|
3,436 |
2,911 |
$30K |
| 97014 |
|
1,083 |
387 |
$30K |
| 93923 |
|
344 |
302 |
$30K |
| 43235 |
|
95 |
70 |
$29K |
| 82565 |
|
7,536 |
5,738 |
$29K |
| A0434 |
Specialty care transport (sct) |
182 |
178 |
$29K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
292 |
284 |
$29K |
| 86003 |
|
1,563 |
700 |
$28K |
| 77065 |
Tomosynthesis, mammo |
681 |
560 |
$28K |
| 86480 |
|
556 |
495 |
$28K |
| 77080 |
|
431 |
389 |
$28K |
| 95886 |
|
271 |
225 |
$27K |
| 74178 |
|
130 |
98 |
$27K |
| 77066 |
Tomosynthesis, mammo |
622 |
554 |
$27K |
| 87522 |
Neg quan hep c or qual rna |
571 |
494 |
$26K |
| 64483 |
|
68 |
52 |
$26K |
| 95714 |
|
20 |
12 |
$26K |
| 96376 |
|
16,891 |
8,073 |
$26K |
| 82105 |
|
1,159 |
1,017 |
$26K |
| 99152 |
|
1,009 |
716 |
$26K |
| 86225 |
|
1,069 |
911 |
$25K |
| 93880 |
|
320 |
276 |
$25K |
| 87340 |
|
1,854 |
1,539 |
$25K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
236 |
231 |
$25K |
| 74019 |
|
440 |
392 |
$25K |
| 83690 |
|
38,222 |
29,486 |
$24K |
| 83605 |
|
11,502 |
6,973 |
$24K |
| 29881 |
|
21 |
12 |
$23K |
| 84481 |
|
952 |
833 |
$23K |
| 90698 |
|
3,284 |
3,228 |
$23K |
| 99153 |
Mod sedat endo service >5yrs |
677 |
475 |
$23K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
2,044 |
1,983 |
$23K |
| 82784 |
|
1,465 |
959 |
$23K |
| 86901 |
|
4,817 |
3,708 |
$22K |
| 11721 |
|
801 |
758 |
$22K |
| 85652 |
|
4,571 |
3,461 |
$22K |
| 72170 |
|
636 |
494 |
$21K |
| 77301 |
|
20 |
14 |
$21K |
| 73110 |
|
2,489 |
1,973 |
$21K |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
1,449 |
961 |
$20K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
149 |
144 |
$20K |
| 86920 |
|
916 |
433 |
$20K |
| 73080 |
|
1,622 |
1,292 |
$20K |
| 82785 |
|
832 |
708 |
$20K |
| A0436 |
Rotary wing air mileage, per statute mile |
222 |
214 |
$20K |
| C8908 |
Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral |
69 |
54 |
$19K |
| 80074 |
|
965 |
815 |
$19K |
| 64415 |
|
63 |
42 |
$19K |
| 72156 |
|
194 |
155 |
$19K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
5,841 |
5,746 |
$19K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
52 |
50 |
$19K |
| 90633 |
|
1,971 |
1,946 |
$19K |
| 99201 |
|
212 |
212 |
$19K |
| 93225 |
|
228 |
194 |
$19K |
| 85730 |
|
6,822 |
5,289 |
$19K |
| 86317 |
|
900 |
763 |
$18K |
| 80051 |
|
3,310 |
2,545 |
$18K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
274 |
202 |
$17K |
| 72158 |
|
125 |
101 |
$17K |
| 80323 |
|
640 |
573 |
$17K |
| 90744 |
|
2,119 |
2,077 |
$17K |
| 72082 |
|
209 |
194 |
$16K |
| 64447 |
|
136 |
97 |
$16K |
| 81025 |
|
17,665 |
13,833 |
$16K |
| 62323 |
|
48 |
35 |
$16K |
| 52000 |
|
20 |
15 |
$16K |
| 87186 |
|
4,564 |
3,306 |
$16K |
| 87641 |
|
554 |
478 |
$16K |
| 19083 |
|
15 |
12 |
$16K |
| 84146 |
|
662 |
553 |
$16K |
| 84703 |
|
28,034 |
22,481 |
$15K |
| 11043 |
|
90 |
49 |
$15K |
| 86038 |
|
1,047 |
892 |
$15K |
| 72110 |
|
307 |
282 |
$15K |
| 73590 |
|
1,553 |
1,228 |
$15K |
| 81003 |
|
9,548 |
7,420 |
$15K |
| 84630 |
|
583 |
524 |
$15K |
| G0009 |
Administration of pneumococcal vaccine |
4,400 |
4,264 |
$15K |
| 85379 |
|
8,346 |
6,627 |
$14K |
| 84153 |
|
868 |
766 |
$14K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
140 |
129 |
$14K |
| 72072 |
|
657 |
538 |
$14K |
| 87480 |
|
12,838 |
10,372 |
$14K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
32 |
25 |
$14K |
| 92611 |
|
230 |
199 |
$14K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
1,071 |
951 |
$13K |
| 82043 |
|
1,815 |
1,635 |
$13K |
| 70360 |
|
483 |
389 |
$13K |
| 84403 |
|
642 |
559 |
$13K |
| 86762 |
|
746 |
599 |
$13K |
| 84550 |
|
1,866 |
1,612 |
$13K |
| 87902 |
|
61 |
50 |
$12K |
| 72050 |
|
241 |
228 |
$12K |
| S9445 |
Patient education, not otherwise classified, non-physician provider, individual, per session |
253 |
167 |
$12K |
| 73564 |
|
458 |
375 |
$12K |
| 82533 |
|
1,601 |
1,059 |
$12K |
| 90680 |
|
2,243 |
2,197 |
$12K |
| 76882 |
|
101 |
88 |
$11K |
| 94010 |
|
493 |
466 |
$11K |
| 84590 |
|
526 |
468 |
$11K |
| 73090 |
|
1,314 |
997 |
$10K |
| 94660 |
|
124 |
68 |
$10K |
| 73560 |
|
220 |
168 |
$10K |
| 84425 |
|
661 |
587 |
$9K |
| 84100 |
|
3,319 |
2,412 |
$9K |
| 76870 |
|
598 |
500 |
$9K |
| 84520 |
|
5,702 |
4,090 |
$9K |
| 94776 |
|
159 |
133 |
$9K |
| 82670 |
|
350 |
301 |
$9K |
| 64450 |
|
35 |
24 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
5,822 |
5,031 |
$9K |
| 80164 |
|
746 |
575 |
$9K |
| 90688 |
|
762 |
743 |
$9K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
14,425 |
8,093 |
$8K |
| 59025 |
Fetal non-stress test |
75 |
62 |
$8K |
| 54161 |
|
15 |
13 |
$8K |
| 86403 |
|
1,667 |
1,194 |
$8K |
| 77338 |
|
21 |
15 |
$8K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
15,859 |
6,967 |
$8K |
| 76775 |
|
85 |
68 |
$8K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
1,575 |
727 |
$8K |
| 83001 |
|
474 |
420 |
$8K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
9,827 |
4,810 |
$8K |
| 82330 |
|
2,880 |
2,061 |
$8K |
| 87077 |
|
2,933 |
2,129 |
$8K |
| 85045 |
|
1,418 |
940 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
18,623 |
8,069 |
$8K |
| 82248 |
|
792 |
667 |
$7K |
| 86376 |
|
354 |
309 |
$7K |
| G0010 |
Administration of hepatitis b vaccine |
2,089 |
2,050 |
$7K |
| 73140 |
|
276 |
236 |
$7K |
| 00731 |
|
2,721 |
2,059 |
$7K |
| 86147 |
|
221 |
89 |
$7K |
| 73552 |
|
684 |
537 |
$7K |
| 73100 |
|
164 |
111 |
$7K |
| 72146 |
|
64 |
58 |
$7K |
| 84156 |
|
1,686 |
1,333 |
$7K |
| 81241 |
|
97 |
77 |
$6K |
| 92587 |
|
54 |
54 |
$6K |
| 86704 |
|
376 |
333 |
$6K |
| 92551 |
|
65 |
64 |
$6K |
| 82140 |
|
1,107 |
769 |
$6K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
7,259 |
3,001 |
$6K |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
240 |
53 |
$6K |
| 83002 |
|
372 |
328 |
$6K |
| J1453 |
Injection, fosaprepitant, 1 mg |
527 |
240 |
$6K |
| 85014 |
|
4,086 |
2,598 |
$5K |
| 86787 |
|
156 |
136 |
$5K |
| 64400 |
|
25 |
12 |
$5K |
| 87040 |
|
4,454 |
1,907 |
$5K |
| 71101 |
|
667 |
562 |
$5K |
| 97163 |
|
91 |
81 |
$5K |
| 84132 |
|
2,825 |
1,832 |
$5K |
| 86334 |
|
272 |
210 |
$5K |
| 84460 |
|
793 |
677 |
$5K |
| 86431 |
|
274 |
233 |
$5K |
| 95819 |
|
29 |
26 |
$5K |
| 83521 |
|
679 |
341 |
$5K |
| 82977 |
|
436 |
330 |
$5K |
| 64636 |
|
416 |
266 |
$5K |
| 90677 |
|
19 |
19 |
$5K |
| 92523 |
|
81 |
53 |
$5K |
| 84165 |
|
547 |
423 |
$5K |
| 82378 |
|
647 |
380 |
$4K |
| 73060 |
|
653 |
514 |
$4K |
| 51798 |
|
706 |
511 |
$4K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
9,379 |
5,873 |
$4K |
| 74022 |
|
602 |
462 |
$4K |
| J1953 |
Injection, levetiracetam, 10 mg |
825 |
491 |
$4K |
| 82550 |
|
2,189 |
1,496 |
$4K |
| 81002 |
|
670 |
584 |
$4K |
| 75574 |
|
13 |
12 |
$4K |
| 90696 |
|
451 |
443 |
$4K |
| 82950 |
|
335 |
275 |
$4K |
| 88172 |
|
42 |
27 |
$4K |
| 83615 |
|
954 |
725 |
$4K |
| 90685 |
|
427 |
421 |
$4K |
| 84480 |
|
150 |
130 |
$4K |
| 90710 |
|
703 |
692 |
$4K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
1,088 |
851 |
$4K |
| 80177 |
|
1,043 |
740 |
$4K |
| 84450 |
|
679 |
571 |
$4K |
| 83520 |
|
132 |
81 |
$4K |
| A0426 |
Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) |
46 |
46 |
$3K |
| 87088 |
|
1,752 |
1,382 |
$3K |
| 80143 |
|
3,456 |
2,596 |
$3K |
| C1776 |
Joint device (implantable) |
297 |
223 |
$3K |
| 85018 |
|
1,707 |
979 |
$3K |
| 97802 |
|
40 |
37 |
$3K |
| 20610 |
|
42 |
28 |
$3K |
| 83883 |
|
73 |
58 |
$3K |
| 87070 |
|
1,440 |
1,044 |
$3K |
| 82803 |
|
2,150 |
1,471 |
$3K |
| 84145 |
|
1,013 |
764 |
$3K |
| 77072 |
|
40 |
38 |
$3K |
| 90716 |
|
356 |
349 |
$3K |
| 96368 |
|
1,301 |
691 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
45,982 |
33,607 |
$3K |
| 86695 |
|
146 |
115 |
$3K |
| J9045 |
Injection, carboplatin, 50 mg |
258 |
122 |
$3K |
| 93226 |
|
55 |
43 |
$3K |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
324 |
181 |
$3K |
| 87205 |
|
1,877 |
1,231 |
$3K |
| 83874 |
|
2,644 |
1,640 |
$3K |
| 86696 |
|
146 |
115 |
$3K |
| 12013 |
|
16 |
14 |
$3K |
| 76981 |
|
30 |
27 |
$3K |
| 83013 |
|
42 |
27 |
$2K |
| 86694 |
|
130 |
101 |
$2K |
| 87449 |
|
380 |
290 |
$2K |
| 78264 |
|
13 |
12 |
$2K |
| 97750 |
|
31 |
25 |
$2K |
| 73718 |
|
14 |
14 |
$2K |
| J2785 |
Injection, regadenoson, 0.1 mg |
1,676 |
1,336 |
$2K |
| 81000 |
|
246 |
234 |
$2K |
| 82435 |
|
988 |
670 |
$2K |
| 85049 |
|
1,069 |
759 |
$2K |
| 69210 |
|
99 |
99 |
$2K |
| 82310 |
|
429 |
349 |
$2K |
| 86708 |
|
80 |
66 |
$2K |
| 90707 |
|
351 |
344 |
$2K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
304 |
287 |
$2K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
17 |
15 |
$2K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
23,681 |
14,605 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,066 |
1,495 |
$2K |
| 86644 |
|
92 |
76 |
$2K |
| 76885 |
|
12 |
12 |
$2K |
| 81240 |
|
67 |
52 |
$2K |
| 87324 |
|
260 |
200 |
$2K |
| 82652 |
|
81 |
66 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
22,869 |
11,631 |
$2K |
| 00400 |
|
530 |
369 |
$2K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
1,000 |
298 |
$2K |
| 86777 |
|
63 |
52 |
$2K |
| J2790 |
Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) |
20 |
12 |
$2K |
| 84295 |
|
1,318 |
882 |
$2K |
| 80179 |
|
3,390 |
2,561 |
$2K |
| 84436 |
|
187 |
167 |
$2K |
| 90734 |
|
337 |
292 |
$2K |
| 86665 |
|
65 |
24 |
$2K |
| 80326 |
|
185 |
162 |
$2K |
| 82951 |
|
53 |
42 |
$2K |
| 84270 |
|
66 |
59 |
$1K |
| 88280 |
|
15 |
12 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
7,180 |
4,465 |
$1K |
| 90700 |
|
206 |
204 |
$1K |
| 86308 |
|
528 |
411 |
$1K |
| 76937 |
|
76 |
70 |
$1K |
| 90714 |
|
90 |
81 |
$1K |
| 90732 |
|
79 |
76 |
$1K |
| 86645 |
|
79 |
66 |
$1K |
| 82627 |
|
69 |
56 |
$1K |
| 82150 |
|
1,955 |
1,336 |
$1K |
| 77073 |
|
17 |
15 |
$1K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
238 |
164 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
26,114 |
20,043 |
$1K |
| G0379 |
Direct admission of patient for hospital observation care |
154 |
107 |
$1K |
| 82040 |
|
481 |
391 |
$1K |
| 64494 |
|
516 |
341 |
$1K |
| 86800 |
|
70 |
52 |
$1K |
| 00910 |
|
514 |
363 |
$1K |
| 86778 |
|
61 |
52 |
$1K |
| 64445 |
|
29 |
13 |
$1K |
| 96417 |
|
1,225 |
619 |
$1K |
| 73620 |
|
51 |
45 |
$1K |
| 87075 |
|
943 |
659 |
$1K |
| G0296 |
Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) |
13 |
13 |
$1K |
| 82103 |
|
92 |
80 |
$1K |
| 82247 |
|
151 |
109 |
$1K |
| 86160 |
|
102 |
41 |
$1K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
6,113 |
3,885 |
$1K |
| 76942 |
|
233 |
174 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
44,545 |
29,352 |
$994.20 |
| 01992 |
|
184 |
158 |
$980.24 |
| 90648 |
|
102 |
102 |
$979.80 |
| 83721 |
|
58 |
52 |
$968.24 |
| 83020 |
|
50 |
42 |
$966.50 |
| 80175 |
|
220 |
179 |
$961.11 |
| 83090 |
|
73 |
53 |
$953.16 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
13,019 |
7,248 |
$943.49 |
| 80355 |
|
127 |
109 |
$932.71 |
| C1769 |
Guide wire |
1,868 |
1,269 |
$921.11 |
| 82397 |
|
33 |
25 |
$905.25 |
| 83993 |
|
44 |
39 |
$897.99 |
| C1889 |
Implantable/insertable device, not otherwise classified |
547 |
387 |
$893.94 |
| 86304 |
|
51 |
38 |
$853.46 |
| 86747 |
|
52 |
26 |
$845.17 |
| 97597 |
|
23 |
12 |
$840.37 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
2,650 |
1,858 |
$839.57 |
| 88342 |
|
1,795 |
1,247 |
$831.77 |
| 00940 |
|
25 |
14 |
$806.24 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
20,438 |
13,187 |
$787.35 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
363 |
280 |
$777.13 |
| 97035 |
|
64 |
25 |
$775.64 |
| 72120 |
|
16 |
15 |
$774.11 |
| 72070 |
|
37 |
36 |
$754.26 |
| J1644 |
Injection, heparin sodium, per 1000 units |
5,415 |
1,563 |
$704.12 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
3,796 |
2,416 |
$701.78 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
13,739 |
9,360 |
$647.54 |
| 80347 |
|
82 |
68 |
$645.77 |
| J1456 |
Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg |
96 |
51 |
$633.37 |
| 82952 |
|
39 |
30 |
$632.12 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,771 |
954 |
$605.80 |
| 73521 |
|
13 |
13 |
$600.10 |
| 73000 |
|
19 |
14 |
$596.54 |
| 87807 |
|
1,161 |
979 |
$583.85 |
| 85613 |
|
84 |
67 |
$583.81 |
| 29125 |
|
760 |
630 |
$582.64 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
886 |
554 |
$554.47 |
| 01480 |
|
379 |
260 |
$533.44 |
| 90620 |
|
51 |
51 |
$529.40 |
| 82962 |
|
260 |
239 |
$527.07 |
| 90746 |
|
31 |
30 |
$496.82 |
| 85576 |
|
20 |
13 |
$495.50 |
| 85300 |
|
42 |
38 |
$492.15 |
| C9113 |
Injection, pantoprazole sodium, per vial |
946 |
460 |
$488.88 |
| 90846 |
Family psychotherapy without the patient present, 50 minutes |
14 |
12 |
$477.45 |
| 72220 |
|
45 |
38 |
$471.18 |
| 82010 |
|
1,339 |
950 |
$461.35 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,733 |
985 |
$452.28 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
791 |
569 |
$450.01 |
| 77002 |
|
13 |
13 |
$445.42 |
| 85306 |
|
63 |
40 |
$435.86 |
| 84155 |
|
79 |
73 |
$427.18 |
| 83010 |
|
36 |
26 |
$402.73 |
| 00813 |
|
1,076 |
789 |
$395.59 |
| 01400 |
|
52 |
29 |
$395.59 |
| 00840 |
|
338 |
213 |
$395.59 |
| 00811 |
|
937 |
693 |
$395.59 |
| 00812 |
|
806 |
594 |
$395.59 |
| 83527 |
|
20 |
14 |
$354.26 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
4,029 |
2,456 |
$341.14 |
| 85651 |
|
138 |
124 |
$338.91 |
| 82270 |
|
111 |
82 |
$338.22 |
| 83930 |
|
154 |
109 |
$332.47 |
| 82390 |
|
25 |
18 |
$326.80 |
| 93320 |
|
40 |
38 |
$316.50 |
| J0280 |
Injection, aminophyllin, up to 250 mg |
88 |
79 |
$311.60 |
| 88112 |
|
18 |
15 |
$301.14 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
1,327 |
940 |
$296.81 |
| 84305 |
|
13 |
12 |
$288.37 |
| J2060 |
Injection, lorazepam, 2 mg |
3,074 |
1,937 |
$286.91 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
2,974 |
1,769 |
$273.82 |
| 80364 |
|
82 |
68 |
$267.32 |
| 00104 |
|
242 |
97 |
$266.72 |
| 86301 |
|
33 |
24 |
$242.24 |
| 85303 |
|
35 |
26 |
$239.17 |
| 74220 |
|
14 |
12 |
$227.51 |
| 88304 |
|
867 |
627 |
$223.99 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
1,830 |
843 |
$220.12 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
2,084 |
1,606 |
$217.07 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
375 |
121 |
$213.46 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
1,388 |
993 |
$208.44 |
| 84300 |
|
135 |
103 |
$194.44 |
| 73600 |
|
20 |
12 |
$182.92 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
1,119 |
615 |
$182.82 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
354 |
230 |
$180.22 |
| 84478 |
|
27 |
13 |
$171.32 |
| P9603 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled |
2,818 |
1,464 |
$164.37 |
| J1790 |
Injection, droperidol, up to 5 mg |
1,372 |
893 |
$163.40 |
| 86300 |
|
43 |
25 |
$160.73 |
| 82272 |
|
33 |
29 |
$153.43 |
| 87076 |
|
60 |
26 |
$152.33 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
292 |
164 |
$149.83 |
| 77001 |
|
45 |
37 |
$149.82 |
| 96402 |
|
18 |
13 |
$139.40 |
| 73070 |
|
17 |
12 |
$120.01 |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,816 |
828 |
$116.19 |
| 84075 |
|
32 |
26 |
$114.38 |
| 82274 |
|
12 |
12 |
$112.97 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,712 |
1,259 |
$112.96 |
| 80235 |
|
18 |
13 |
$112.60 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
731 |
467 |
$102.47 |
| 87081 |
|
19 |
12 |
$93.12 |
| 88173 |
|
67 |
44 |
$89.48 |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,057 |
674 |
$82.69 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
146 |
89 |
$80.79 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,034 |
908 |
$80.68 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
204 |
186 |
$74.08 |
| 94761 |
|
4,269 |
2,626 |
$66.48 |
| 51702 |
|
49 |
25 |
$66.06 |
| J1940 |
Injection, furosemide, up to 20 mg |
589 |
338 |
$59.89 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
693 |
485 |
$59.61 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,056 |
846 |
$59.57 |
| J3411 |
Injection, thiamine hcl, 100 mg |
756 |
375 |
$58.11 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
870 |
656 |
$56.64 |
| 64484 |
|
19 |
15 |
$54.72 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
2,695 |
1,799 |
$54.57 |
| 80165 |
|
18 |
15 |
$47.86 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
13 |
13 |
$41.44 |
| 87184 |
|
17 |
12 |
$37.90 |
| 85384 |
|
14 |
13 |
$36.44 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
562 |
195 |
$32.90 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
378 |
255 |
$31.03 |
| J8501 |
Aprepitant, oral, 5 mg |
13 |
12 |
$29.10 |
| 82553 |
|
80 |
56 |
$27.20 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
419 |
246 |
$26.39 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
536 |
386 |
$25.30 |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,498 |
794 |
$25.11 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
2,675 |
2,185 |
$24.99 |
| 82800 |
|
73 |
38 |
$24.13 |
| 82375 |
|
13 |
12 |
$23.15 |
| J9190 |
Injection, fluorouracil, 500 mg |
917 |
204 |
$20.16 |
| J0737 |
Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg |
98 |
69 |
$17.86 |
| C1892 |
Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away |
208 |
157 |
$14.51 |
| J0456 |
Injection, azithromycin, 500 mg |
180 |
113 |
$13.72 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
1,506 |
1,060 |
$13.59 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
543 |
451 |
$13.21 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
514 |
341 |
$12.45 |
| 89051 |
|
33 |
27 |
$11.35 |
| J2305 |
Injection, nitroglycerin, 5 mg |
191 |
125 |
$10.88 |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
286 |
128 |
$10.50 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
15 |
15 |
$9.56 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
490 |
329 |
$8.49 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
248 |
169 |
$8.36 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
53 |
27 |
$6.30 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
347 |
107 |
$5.44 |
| H1000 |
Prenatal care, at-risk assessment |
138 |
134 |
$4.49 |
| A9576 |
Injection, gadoteridol, (prohance multipack), per ml |
625 |
512 |
$1.42 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
17 |
14 |
$0.14 |
| 96411 |
|
274 |
128 |
$0.00 |
| C1781 |
Mesh (implantable) |
94 |
60 |
$0.00 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
1,148 |
877 |
$0.00 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
97 |
56 |
$0.00 |
| 88311 |
|
16 |
13 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
265 |
219 |
$0.00 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
424 |
248 |
$0.00 |
| 94760 |
|
1,079 |
706 |
$0.00 |
| 00790 |
|
298 |
199 |
$0.00 |
| 94762 |
|
241 |
192 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
111 |
88 |
$0.00 |
| 00952 |
|
143 |
95 |
$0.00 |
| J9267 |
Injection, paclitaxel, 1 mg |
44 |
14 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
57 |
56 |
$0.00 |
| C9399 |
Unclassified drugs or biologicals |
126 |
87 |
$0.00 |
| A4648 |
Tissue marker, implantable, any type, each |
70 |
54 |
$0.00 |
| 84157 |
|
14 |
13 |
$0.00 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
79 |
19 |
$0.00 |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
393 |
227 |
$0.00 |
| 64495 |
|
209 |
142 |
$0.00 |
| C1760 |
Closure device, vascular (implantable/insertable) |
39 |
27 |
$0.00 |
| A9537 |
Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries |
14 |
12 |
$0.00 |
| 00300 |
|
182 |
121 |
$0.00 |
| 01810 |
|
110 |
67 |
$0.00 |
| C1758 |
Catheter, ureteral |
375 |
220 |
$0.00 |
| 88360 |
|
18 |
12 |
$0.00 |
| 00920 |
|
143 |
140 |
$0.00 |
| 00918 |
|
86 |
56 |
$0.00 |
| C1788 |
Port, indwelling (implantable) |
18 |
16 |
$0.00 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
436 |
333 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
42 |
41 |
$0.00 |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
34 |
27 |
$0.00 |
| 85520 |
|
31 |
12 |
$0.00 |
| C1729 |
Catheter, drainage |
36 |
26 |
$0.00 |
| A4641 |
Radiopharmaceutical, diagnostic, not otherwise classified |
37 |
21 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
42 |
41 |
$0.00 |
| J1956 |
Injection, levofloxacin, 250 mg |
26 |
13 |
$0.00 |